scd40 Search Results


total reactive antioxidant potential trap  (Randox)
92
Randox total reactive antioxidant potential trap
Total Reactive Antioxidant Potential Trap, supplied by Randox, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/total reactive antioxidant potential trap/product/Randox
Average 92 stars, based on 1 article reviews
total reactive antioxidant potential trap - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
hu5c8  (ProSci Incorporated)
94
ProSci Incorporated hu5c8
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Hu5c8, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hu5c8/product/ProSci Incorporated
Average 94 stars, based on 1 article reviews
hu5c8 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
cd40l  (Boster Bio)
91
Boster Bio cd40l
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Cd40l, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd40l/product/Boster Bio
Average 91 stars, based on 1 article reviews
cd40l - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
recombinant human scd40-ligand rhscd40l  (PeproTech)
90
PeproTech recombinant human scd40-ligand rhscd40l
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Recombinant Human Scd40 Ligand Rhscd40l, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human scd40-ligand rhscd40l/product/PeproTech
Average 90 stars, based on 1 article reviews
recombinant human scd40-ligand rhscd40l - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scd40 co 2 sensor  (Sensirion ag)
90
Sensirion ag scd40 co 2 sensor
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Scd40 Co 2 Sensor, supplied by Sensirion ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd40 co 2 sensor/product/Sensirion ag
Average 90 stars, based on 1 article reviews
scd40 co 2 sensor - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scd40  (Adafruit Industries)
90
Adafruit Industries scd40
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Scd40, supplied by Adafruit Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd40/product/Adafruit Industries
Average 90 stars, based on 1 article reviews
scd40 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scd40 mab clone 7  (PanGenetics BV)
90
PanGenetics BV scd40 mab clone 7
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Scd40 Mab Clone 7, supplied by PanGenetics BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd40 mab clone 7/product/PanGenetics BV
Average 90 stars, based on 1 article reviews
scd40 mab clone 7 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scd40-l  (Immunex Corporation)
90
Immunex Corporation scd40-l
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Scd40 L, supplied by Immunex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd40-l/product/Immunex Corporation
Average 90 stars, based on 1 article reviews
scd40-l - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scd40  (HyTest)
90
HyTest scd40
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Scd40, supplied by HyTest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd40/product/HyTest
Average 90 stars, based on 1 article reviews
scd40 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scd40 ligand  (Amgen)
90
Amgen scd40 ligand
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Scd40 Ligand, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd40 ligand/product/Amgen
Average 90 stars, based on 1 article reviews
scd40 ligand - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
rh-scd40 ligand  (ImmunoTools)
90
ImmunoTools rh-scd40 ligand
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Rh Scd40 Ligand, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rh-scd40 ligand/product/ImmunoTools
Average 90 stars, based on 1 article reviews
rh-scd40 ligand - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scd40  (Kamiya)
90
Kamiya scd40
(A) CD40L binding potency of AT-1501 (cyan) and <t>Hu5C8</t> (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.
Scd40, supplied by Kamiya, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd40/product/Kamiya
Average 90 stars, based on 1 article reviews
scd40 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


(A) CD40L binding potency of AT-1501 (cyan) and Hu5C8 (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.

Journal: Science translational medicine

Article Title: The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates

doi: 10.1126/scitranslmed.adf6376

Figure Lengend Snippet: (A) CD40L binding potency of AT-1501 (cyan) and Hu5C8 (orange) was determined by ELISA with recombinant human CD40L (rhuCD40L). Abatacept (purple), a variant of CTLA4-Ig that interferes with the CD28-CD80/86 costimulatory pathway, was used as a negative control. A450, absorbance at 450nm. (B) AT-1501 and Hu5C8 binding to human FcγRI, FcγRIIa, FcγRIIIa, and FcγRIIIb was measured by ELISA. (C to F) PAC-1 expression was measured in platelets from healthy controls incubated with soluble CD40L alone (C), Hu5C8 and sCD40L (D), Hu5C8 F(Ab’)2 lacking an Fc region and sCD40L (E), or AT-1501 and sCD40L (F). Blue tracings represent expression of PAC-1 following incubation with 5μg/mL sCD40L alone and red tracings represent expression of PAC-1 following incubation with the indicated combinations. (G) Platelet aggregation was measured in vitro using platelets incubated with the indicated combinations.

Article Snippet: FcγR binding assays ELISAs were run with Hu5C8 (ProSci, XP-5263BT), an anti-CD40L antibody, as a positive control.

Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Recombinant, Variant Assay, Negative Control, Expressing, Incubation, In Vitro